Phase II clinical trial of GM2-KLH/QS-21 (GMK) vaccine in patients with malignant melanoma Meeting Abstract


Authors: Israel, R. J.; Chapman, P.; Myers, M.; Hamilton, W. B.; Chang, C. H.; Zhan, C.; Morrissey, D.; Livingston, P.
Abstract Title: Phase II clinical trial of GM2-KLH/QS-21 (GMK) vaccine in patients with malignant melanoma
Meeting Title: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy
Journal Title: Annals of Oncology
Volume: 9
Issue: Suppl. 2
Meeting Dates: 1998 Jun 16-19
Meeting Location: Amsterdam, Netherlands
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 1998-05-01
Start Page: 85
Language: English
ACCESSION: WOS:000074749600294
PROVIDER: wos
PUBMED: 9781244
Notes: Meeting Abstract: 322 -- Source: Wos
Citation Impact
MSK Authors
  1. Paul Chapman
    326 Chapman